Law.com Radar In Samaniego v. Eli Lilly & Co., the plaintiff began posting scripture passages during a discussion of Pride Month on the company's in-house employee communication system ...

With incoming president Donald Trump threatening a trade war with China, experts told BioSpace that the new administration ...

It was a busy week of high school basketball, giving central Ohio teams a chance to make adjustments. Here are five things we ...

A longtime pharmaceutical executive laments the woeful state of the industry and calls for new leadership to win back public ...

At Clarivate, we take pride in the precision and reliability of our predictions ... Ebglyss (lebrikizumab) developed by Eli Lilly and Co and Almirall|atopic dermatitis. Ebglyss, the third biologic ...

"I pride myself on being a person aiming to do ... where he did his postdoctoral fellowship, for Eli Lilly in Indianapolis. He started as a bench scientist in 1981 working on the biosynthesis ...

Eli Lilly's stock dipped due to cutting Q4 sales targets, despite a strong 2024 performance from Mounjaro and Zepbound. Click ...

All told, Lilly stock still gained 33% in 2024, outperforming the S&P 500 and Nasdaq Composite. Unfortunately, Lilly investors haven't had much to celebrate so far in 2025. On Jan. 14, shares of Lilly ...

We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article, we are going to take a ...